Oramed Pharmaceuticals Gross Margin 2011-2024 | ORMP
Current and historical gross margin for Oramed Pharmaceuticals (ORMP) over the last 10 years. The current gross profit margin for Oramed Pharmaceuticals as of December 31, 2024 is %.
| Oramed Pharmaceuticals Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-06-30 | $0.00B | $0.00B | 100.00% |
| 2023-03-31 | $0.00B | $0.00B | 100.00% |
| 2022-12-31 | $0.00B | $0.00B | 100.00% |
| 2022-09-30 | $0.00B | $0.00B | 100.00% |
| 2022-06-30 | $0.00B | $0.00B | 100.00% |
| 2022-03-31 | $0.00B | $0.00B | 100.00% |
| 2021-11-30 | $0.00B | $0.00B | 100.00% |
| 2021-09-30 | $0.00B | $0.00B | 100.00% |
| 2021-06-30 | $0.00B | $0.00B | 100.00% |
| 2021-05-31 | $0.00B | $0.00B | 100.00% |
| 2021-02-28 | $0.00B | $0.00B | 100.00% |
| 2020-11-30 | $0.00B | $0.00B | 100.00% |
| 2020-02-29 | $0.00B | $0.00B | 100.00% |
| 2019-11-30 | $0.00B | $0.00B | 100.00% |
| 2019-02-28 | $0.00B | $0.00B | 100.00% |
| 2018-11-30 | $0.00B | $0.00B | 100.00% |
| 2018-02-28 | $0.00B | $0.00B | 100.00% |
| 2017-11-30 | $0.00B | $0.00B | 100.00% |
| 2017-02-28 | $0.00B | $0.00B | 50.00% |
| 2016-11-30 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.093B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||